Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
This is a brief. The reporting belongs to NYT Business — read the complete story, with full context and credits, at the source.
Read the full story at NYT Business ↗nytimes.com
More from the Business desk
Just in
Pick the two sectors where earnings growth will accelerate — as long as the 10-year stays below this key level, say strategists
Just in

Former WH Smith chain TG Jones put up for sale after closing 130 stores
Just in
Why Big Investors Are Burning Lenders on Apartment Loans
Just in